Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 18, 943-946, September 1, 1958]
© 1958 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jordan, R. T.
Right arrow Articles by Bierman, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jordan, R. T.
Right arrow Articles by Bierman, H. R.

Effect of Group A Streptococci on Transplantable Leukemia of Mice*

Russell T. Jordan, A. F. Rasmussen, Jr. and Howard R. Bierman

( Depts. of Microbiology and Internal Medicine, City of Hope Medical Center, Duarte, Calif.; and Dept. of Infectious Diseases, Univ. of California, Los Angeles, Calif.)

Two hundred AKR mice with submaxillary tumors produced by the intranasal deposition of ascites-form leukemic cells were superinfected with Group A streptococci at 48- and 72-hour intervals. Of 100 mice which received streptococci 48 hours after instillation of leukemic cells, 54 developed superimposed infection of the tumor-bearing nodes. After treatment with penicillin, 48 mice survived and remained tumor-free. Of the 100 mice which received streptococci 72 hours following tumor transplants, 32 developed superimposed infection of the tumor-bearing nodes. After treatment with penicillin, 26 mice survived and remained tumor-free. Infected tumor-bearing mice survived longer than did uninfected tumor-bearing controls. Mean survival times in days were: tumor control series, 14.5 ± 0.6; 48-hour infected series, 22.6 ± 0.1; and 72-hour infected series, 18.2. Infected tumor-bearing animals in both the 48- and 72-hour series showed a significant absolute increase in survival over the uninfected ascites control mice.

* Project supported by Research Grant C-2641 from National Institutes of Health, U.S. Public Health Service.

Received 4/ 3/58.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1958 by the American Association for Cancer Research.